目次

Table of Contents

List of Tables

List of Figures
Introduction
Global Markets Direct Report Coverage
Respiratory Syncytial Virus (RSV) Infections - Overview
Respiratory Syncytial Virus (RSV) Infections - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Respiratory Syncytial Virus (RSV) Infections - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Respiratory Syncytial Virus (RSV) Infections - Companies Involved in Therapeutics Development
Respiratory Syncytial Virus (RSV) Infections - Drug Profiles
(human metapneumovirus + human respiratory syncytial virus) (bivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
(human parainfluenza virus [serotype 1] + respiratory syncytial virus) vaccine - Drug Profile
Product Description
Mechanism Of Action
(influenza (virus like particle) + respiratory syncytial virus) vaccine - Drug Profile
Product Description
Mechanism Of Action
(influenza + Coronavirus Disease 2019 (COVID-19) + respiratory syncytial virus) vaccine - Drug Profile
Product Description
Mechanism Of Action
(pertussis + respiratory syncytial virus) vaccine - Drug Profile
Product Description
Mechanism Of Action
ABX-196 - Drug Profile
Product Description
Mechanism Of Action
ADV-110 - Drug Profile
Product Description
Mechanism Of Action
AK-0529 - Drug Profile
Product Description
Mechanism Of Action
AK-0610 - Drug Profile
Product Description
Mechanism Of Action
AK-0611 - Drug Profile
Product Description
Mechanism Of Action
AK-0702 - Drug Profile
Product Description
Mechanism Of Action
ALVR-106 - Drug Profile
Product Description
Mechanism Of Action
Antisense RNAi Oligonucleotide for Respiratory Syncytial Virus (RSV) Infections - Drug Profile
Product Description
Mechanism Of Action
AR-201 - Drug Profile
Product Description
Mechanism Of Action
ASN-500 - Drug Profile
Product Description
Mechanism Of Action
AVG-388 - Drug Profile
Product Description
Mechanism Of Action
AZ-27 - Drug Profile
Product Description
Mechanism Of Action
B-1402 - Drug Profile
Product Description
Mechanism Of Action
BC-0005 - Drug Profile
Product Description
Mechanism Of Action
BC-0335 - Drug Profile
Product Description
Mechanism Of Action
BL-200 - Drug Profile
Product Description
Mechanism Of Action
BLB-201 - Drug Profile
Product Description
Mechanism Of Action
CAL-100 - Drug Profile
Product Description
Mechanism Of Action
CDX-RSV - Drug Profile
Product Description
Mechanism Of Action
clesrovimab - Drug Profile
Product Description
Mechanism Of Action
CR-32T - Drug Profile
Product Description
Mechanism Of Action
CT-02 - Drug Profile
Product Description
Mechanism Of Action
dexamethasone sodium phosphate - Drug Profile
Product Description
Mechanism Of Action
DPX-RSV - Drug Profile
Product Description
Mechanism Of Action
Drugs for Respiratory Syncytial Virus - Drug Profile
Product Description
Mechanism Of Action
Drugs for Viral Infections - Drug Profile
Product Description
Mechanism Of Action
DSCav-1 - Drug Profile
Product Description
Mechanism Of Action
EDP-323 - Drug Profile
Product Description
Mechanism Of Action
EDP-938 - Drug Profile
Product Description
Mechanism Of Action
Fusion Proteins for Coronavirus Disease 2019 (COVID-19) and Respiratory Syncytial Virus (RSV) Infections - Drug Profile
Product Description
Mechanism Of Action
GSK-3844766A - Drug Profile
Product Description
Mechanism Of Action
GSK-3888550A - Drug Profile
Product Description
Mechanism Of Action
HEVS-124 - Drug Profile
Product Description
Mechanism Of Action
IB-004R - Drug Profile
Product Description
Mechanism Of Action
immune globulin (human) - Drug Profile
Product Description
Mechanism Of Action
infectious disease vaccine - Drug Profile
Product Description
Mechanism Of Action
IVX-121 - Drug Profile
Product Description
Mechanism Of Action
IVXA-12 - Drug Profile
Product Description
Mechanism Of Action
JNJ-64213175 - Drug Profile
Product Description
Mechanism Of Action
JNJ-64400141 - Drug Profile
Product Description
Mechanism Of Action
JNJ-7184 - Drug Profile
Product Description
Mechanism Of Action
JNJ-78991172 - Drug Profile
Product Description
Mechanism Of Action
JNJ-86051823 - Drug Profile
Product Description
Mechanism Of Action
MM-002 - Drug Profile
Product Description
Mechanism Of Action
MM-004 - Drug Profile
Product Description
Mechanism Of Action
molnupiravir - Drug Profile
Product Description
Mechanism Of Action
Monoclonal Antibodies for Respiratory Syncytial Virus (RSV) Infections - Drug Profile
Product Description
Mechanism Of Action
Monoclonal Antibody for Respiratory Syncytial Virus - Drug Profile
Product Description
Mechanism Of Action
Monoclonal Antibody for Respiratory Syncytial Virus Infections - Drug Profile
Product Description
Mechanism Of Action
Monoclonal Antibody to Inhibit RSV F Protein for Respiratory Syncytial Virus Infections - Drug Profile
Product Description
Mechanism Of Action
MPE-8 - Drug Profile
Product Description
Mechanism Of Action
MPE-8 - Drug Profile
Product Description
Mechanism Of Action
MRIRSM-01 - Drug Profile
Product Description
Mechanism Of Action
MRKV-171 - Drug Profile
Product Description
Mechanism Of Action
mRNA-1230 - Drug Profile
Product Description
Mechanism Of Action
mRNA-1345 - Drug Profile
Product Description
Mechanism Of Action
mRNA-1365 - Drug Profile
Product Description
Mechanism Of Action
MV-012968 - Drug Profile
Product Description
Mechanism Of Action
MVA-BN RSV - Drug Profile
Product Description
Mechanism Of Action
Neumifil - Drug Profile
Product Description
Mechanism Of Action
nirsevimab - Drug Profile
Product Description
Mechanism Of Action
nitazoxanide CR - Drug Profile
Product Description
Mechanism Of Action
P-220241 - Drug Profile
Product Description
Mechanism Of Action
palivizumab biobetter - Drug Profile
Product Description
Mechanism Of Action
palivizumab biosimilar - Drug Profile
Product Description
Mechanism Of Action
palivizumab biosimilar - Drug Profile
Product Description
Mechanism Of Action
palivizumab biosimilar - Drug Profile
Product Description
Mechanism Of Action
pertussis [strain BPZE1] vaccine - Drug Profile
Product Description
Mechanism Of Action
PF-06928316 - Drug Profile
Product Description
Mechanism Of Action
PF-07923567 - Drug Profile
Product Description
Mechanism Of Action
POLB-002 - Drug Profile
Product Description
Mechanism Of Action
Polysaccharides for Viral Infections - Drug Profile
Product Description
Mechanism Of Action
Product Candidates - Drug Profile
Product Description
Mechanism Of Action
Protein for Respiratory Syncytial Virus Infection - Drug Profile
Product Description
Mechanism Of Action
PRTX-007 - Drug Profile
Product Description
Mechanism Of Action
PSP-008 - Drug Profile
Product Description
Mechanism Of Action
ramatroban - Drug Profile
Product Description
Mechanism Of Action
RB-0026 - Drug Profile
Product Description
Mechanism Of Action
RBS-3149 - Drug Profile
Product Description
Mechanism Of Action
Recombinant Protein for Infectious Disease and Oncology - Drug Profile
Product Description
Mechanism Of Action
Recombinant Protein for RSV Infections - Drug Profile
Product Description
Mechanism Of Action
Recombinant Surfactant Associated Protein D Replacement for SARS and RSV Infections - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus (virus like particle) vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus (virus like particle) vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus (virus like particle) vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus (virus like particle) vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus (virus like particle) vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus (virus like particle) vaccines - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus (virus like particles) vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus [strain 98-25147-X] vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus [strain A/Maryland/001/11] vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine 1 - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine 1 - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine 1 - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine 1 - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine 2 - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine 3 - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine 3 - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine 4 - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine 5 - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine 6 - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccine 7 - Drug Profile
Product Description
Mechanism Of Action
respiratory syncytial virus vaccines - Drug Profile
Product Description
Mechanism Of Action
REVTx-99 - Drug Profile
Product Description
Mechanism Of Action
rilematovir - Drug Profile
Product Description
Mechanism Of Action
RLS-0071 - Drug Profile
Product Description
Mechanism Of Action
RSV - Drug Profile
Product Description
Mechanism Of Action
RSV - Drug Profile
Product Description
Mechanism Of Action
RSV - Drug Profile
Product Description
Mechanism Of Action
RSV - Drug Profile
Product Description
Mechanism Of Action
RSV Antivirals - Drug Profile
Product Description
Mechanism Of Action
RSV Artificial Intelligence Drug Discovery Program - Drug Profile
Product Description
Mechanism Of Action
RSV DFC - Drug Profile
Product Description
Mechanism Of Action
RSV Program - Drug Profile
Product Description
Mechanism Of Action
RSV Vaccine - Drug Profile
Product Description
Mechanism Of Action
RSV-276 - Drug Profile
Product Description
Mechanism Of Action
RSV-F005 - Drug Profile
Product Description
Mechanism Of Action
S-337395 - Drug Profile
Product Description
Mechanism Of Action
sisunatovir hydrochloride - Drug Profile
Product Description
Mechanism Of Action
Small Molecule 1 for Respiratory Syncytial Virus Infections - Drug Profile
Product Description
Mechanism Of Action
Small Molecule for Respiratory Syncytial Virus (RSV) Infections - Drug Profile
Product Description
Mechanism Of Action
Small Molecule for Respiratory Syncytial Virus Infections - Drug Profile
Product Description
Mechanism Of Action
Small Molecule to Inhibit RSV F Protein for Respiratory Syncytial Virus Infection - Drug Profile
Product Description
Mechanism Of Action
Small Molecules 2 for Respiratory Syncytial Virus Infections - Drug Profile
Product Description
Mechanism Of Action
Small Molecules for Respiratory Syncytial Virus (RSV) Infections - Drug Profile
Product Description
Mechanism Of Action
Small Molecules for Respiratory Syncytial Virus Infections - Drug Profile
Product Description
Mechanism Of Action
Small Molecules to Inhibit RSV F Protein for Respiratory Syncytial Virus Infection - Drug Profile
Product Description
Mechanism Of Action
SP-0125 - Drug Profile
Product Description
Mechanism Of Action
Syncytial Virus Fusion Inhibitor - Drug Profile
Product Description
Mechanism Of Action
TCB-029 - Drug Profile
Product Description
Mechanism Of Action
TD-214 - Drug Profile
Product Description
Mechanism Of Action
TE-4308 - Drug Profile
Product Description
Mechanism Of Action
TNM-001 - Drug Profile
Product Description
Mechanism Of Action
TP-0591816 - Drug Profile
Product Description
Mechanism Of Action
TRL-3D3 - Drug Profile
Product Description
Mechanism Of Action
TVB-3567 - Drug Profile
Product Description
Mechanism Of Action
TVX-004IP - Drug Profile
Product Description
Mechanism Of Action
verdinexor - Drug Profile
Product Description
Mechanism Of Action
VIS-RSV - Drug Profile
Product Description
Mechanism Of Action
VMT-3 - Drug Profile
Product Description
Mechanism Of Action
VMTX-002 - Drug Profile
Product Description
Mechanism Of Action
VN-0200 - Drug Profile
Product Description
Mechanism Of Action
VPI-251 - Drug Profile
Product Description
Mechanism Of Action
VXB-211 - Drug Profile
Product Description
Mechanism Of Action
VXX-005 - Drug Profile
Product Description
Mechanism Of Action
WLBU-2 - Drug Profile
Product Description
Mechanism Of Action
XW-001 - Drug Profile
Product Description
Mechanism Of Action
YH-009 - Drug Profile
Product Description
Mechanism Of Action
zapnometinib - Drug Profile
Product Description
Mechanism Of Action
zelpultide alfa - Drug Profile
Product Description
Mechanism Of Action
Respiratory Syncytial Virus (RSV) Infections - Dormant Projects
Respiratory Syncytial Virus (RSV) Infections - Discontinued Products
Respiratory Syncytial Virus (RSV) Infections - Product Development Milestones
Featured News & Press Releases
Oct 23, 2022: GSK's older adult respiratory syncytial virus (RSV) vaccine candidate shows 94.1% reduction in severe RSV disease and overall vaccine efficacy of 82.6% in pivotal trial
Oct 18, 2022: Enanta doses first participant in Phase I RSV treatment trial
Oct 07, 2022: Ark Biopharmaceutical presents positive results in phase 3 AIRFLO study of ziresovir in RSV-infected hospitalized infants at 12th International RSV Symposium
Oct 04, 2022: Enanta commences Phase IIb trial of RSV treatment
Oct 04, 2022: Icosavax initiates phase 1 trial of IVX-A12 against RSV and hMPV in older adults
Oct 02, 2022: Enanta Pharmaceuticals announces new preclinical data for its respiratory virology programs to be presented at the 12th International RSV Symposium
Sep 29, 2022: Enanta Pharmaceuticals presents preclinical data for its respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) programs at the 12th International RSV Symposium
Sep 16, 2022: Beyfortus (nirsevimab) recommended for approval in the EU by CHMP for the prevention of RSV lower respiratory tract disease in infants
Aug 26, 2022: Pfizer reports positive Phase III data for bivalent RSV vaccine in adults
Aug 12, 2022: NIHR and Sanofi announce first patient enrolled in large European clinical study to investigate protection against RSV, the leading cause of infant hospitalisation worldwide
Jul 22, 2022: Blue Lake enrols first subject in Phase I RSV vaccine trial
Jun 28, 2022: Icosavax announces positive topline interim phase 1/1b results for VLP vaccine candidate IVX-121 against RSV
Jun 28, 2022: Bavarian Nordic announces grant of PRIME eligibility from the European Medicines Agency for its RSV vaccine candidate for the prevention of respiratory syncytial virus in older adults
Jun 24, 2022: Oral antiviral drug effective against respiratory syncytial virus (RSV) identified by biomedical sciences researchers
Jun 13, 2022: GSK reports positive Phase III data for RSV vaccine in elderly
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Respiratory Syncytial Virus (RSV) Infections, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Respiratory Syncytial Virus (RSV) Infections - Dormant Projects, 2022
Respiratory Syncytial Virus (RSV) Infections - Discontinued Products, 2022

List of Figures
Number of Products under Development for Respiratory Syncytial Virus (RSV) Infections, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022